1-2 of 2
Istvan Majer, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Carfilzomib 56mg/m2 Twice-Weekly in Combination with Dexamethasone and Daratumumab (KdD) Versus Daratumumab in Combination with 8 Cycles of Bortezomib and Dexamethasone (DVd); A Matching-Adjusted Indirect Treatment Comparison

Katja Weisel, MD, Ajay Nooka, MDMPH, Evangelos Terpos, MDPhD, Andrew Spencer, Hartmut Goldschmidt, MD, Istvan Majer, PhD, Lucy DeCosta, MSc, Rohan Medhekar, PhD, Akeem Yusuf, PhD BPharm, Shaji K. Kumar, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-141995
Published: 2020
Journal Articles

Evolving Unmet Need in Patients Refractory to Lenalidomide: Overview of the Clinical Trials in Relapsed/Refractory Multiple Myeloma

Maria-Victoria Mateos, MD PhD, Rohan Medhekar, PhD, Istvan Majer, PhD, Mehmet Turgut, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
https://doi.org/10.1182/blood-2020-142642
Published: 2020